ORAMEC DRENCH FOR SHEEP 0.8 MG/ML
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
28-10-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
IVERMECTIN
Available from:
Merial Animal Health Limited
ATC code:
QP54AA01
INN (International Name):
IVERMECTIN
Dosage:
0.8 Mg/Ml
Pharmaceutical form:
Oral Solution
Prescription type:
LM-Licensed Merchant
Therapeutic group:
Ovine
Therapeutic area:
Ivermectin
Therapeutic indications:
Endectoparasiticides
Authorization status:
Authorised
Authorization date:
1994-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
ORAMEC Drench for Sheep 0.8 mg/ml
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
ORAMEC Drench for Sheep is highly effective for the treatment and control of mixed infections with the following
gastrointestinal roundworms (including benzimidazole-resistant strains of _Haemonchus contortus_, _Ostertagia circumcincta_
and levamisole-resistant strains of _H. contortus, O. circumcincta _and _T. colubriformis_):
GASTROINTESTINAL ROUNDWORMS (adult and fourth larval stage)
_Haemonchus contortus*_
_Ostertagia circumcincta*_
_Trichostrongylus _spp_._
_Cooperia _spp_._
_Nematodirus _spp_._
Including _N. battus_
_Strongyloides papillosus_
_Oesophagostomum _spp.
_Chabertia ovina_
LUNGWORMS (adult and fourth larval stage)
_Dictyocaulus filaria_
NASAL BOT (all larval stages)
_Oestrus ovis_
* including benzimidazole resistant strains.
Active substance
Ivermectin
0.8 mg/ml
Excipients
Benzyl Alcohol
31.0 mg/ml
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 13/10/2015_
_CRN 7022054_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use in animals with known hypersensitivity to the active ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could
ultimately result in ineffective therapy:
·
Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
·
Underdosing which may be due to underestimation of bodyweight, misadmin
Read the complete document
